Cachexia: Clinical Trials

300 trials for Cachexia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

159 completed, 44 recruiting, 43 unknown, 24 terminated. 107 Not applicable, 49 Phase 2, 33 Phase 3, 28 Phase 1, 3 Early Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable107Completed 54, Unknown 24, Recruiting 13, Not yet recruiting 4, Terminated 4, Withdrawn 4, Active not recruiting 3, Enrolling by invitation 1
Phase 249Completed 29, Terminated 6, Recruiting 5, Unknown 4, Not yet recruiting 3, Withdrawn 2
Phase 333Completed 21, Terminated 4, Recruiting 3, Unknown 3, Not yet recruiting 1, Suspended 1
Phase 128Completed 21, Recruiting 4, Not yet recruiting 2, Terminated 1
Early Phase 13Active not recruiting 1, Completed 1, Recruiting 1
Phase 43Completed 1, Unknown 1, Withdrawn 1

Follow this condition Literature Review of Cachexia trials Research Report on Cachexia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
Endothelial cell collection - Obesity and Obesity-related Medical Conditions, Diabetes
RecruitingBettina Mittendorfer1002027-01-012026-05-07
Building Opportunities for Nurturing Care to Enhance Child Development in Eastern and Southern Africa
Friendship Bench, Infant and Young Child Feeding (IYCF) Curriculum, Play-Based Curriculum - Neurodevelopment, Child Growth
Not applicableNot yet recruitingUniversity of Washington12602026-11-012026-03-03
A Study to Learn About the Study Medicine Called Ponsegromab in Adults With Lung Cancer-Associated Significant Body Weight Loss
ponsegromab, placebo - Non-small Cell Lung Cancer (NSCLC), Cachexia
Phase 1Not yet recruitingPfizer802026-10-232026-09-25
A Multimodal Integrated Intervention for Kidney Cachexia
Multi-Modal Integrated Intervention Combining Exercise, Anti-inflammatory & Dietary Advice (MMIEAD) - Cachexia, CKD
Not applicableRecruitingQueen's University, Belfast402026-09-012026-08-26
Hospital-Based Prospective Cohort of Malnutrition Under 6-Month Study (HOSPIC-6-Study)
Not applicable- observational study - Malnutrition, Infant, Malnutrition
RecruitingUniversitas Indonesia17802026-08-282026-10-20
Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life
Hand grip strength assessments using a dynamometer - Pancreatic Ductal Adenocarcinoma (PDAC), Hand Grip Strength
Not applicableRecruitingBritish Columbia Cancer Agency502026-08-132026-09-15
Effectiveness of Positive Deviance/Hearth in Treating Uncomplicated Moderate Acute Malnutrition in Children 6-59 Months in Mymensingh Division, Bangladesh
PD/Hearth is a behavioral change program that teaches caregivers how to cook and feed their children. A nutrient-dense meal using local ingredients will be fed to children during Hearth sessions., Standard of Care (Investigator Selected) - Moderate Acute Malnutrition (MAM), Undernutrition
Not applicableEnrolling by invitationWorld Vision US4002026-07-082026-10-21
Nanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy
Nanocrystalline megestrol acetate, Placebo - Hepatocellular Carcinoma (HCC), Cachexia
Phase 2Not yet recruitingNanfang Hospital, Southern Medical University882026-06-222026-05-04
A Phase I Clinical Study to Evaluate the Efficacy and Safety of GB18 Injection in Patients With Tumor Cachexia
GB18 - Cachexia; Cancer
Phase 1RecruitingKexing Biopharm Co., Ltd.182026-06-102026-06-12
Phase 2 Cachexia Clinical Trial to Evaluate the Efficacy and Safety of ASCA101
Active Comparator, ASCA101 24.32mg/kg, ASCA101 32.43mg/kg - Cachexia; Cancer
Phase 2RecruitingMetaFines1352026-05-082026-06-17
Regular Growth Monitoring (RGM) of Young Children in Guinea-Bissau
Regular Growth Monitoring (RGM) by Community Health Agents - Severe Acute Malnutrition, Moderate Acute Malnutrition (MAM)
Not applicableActive not recruitingTrustees of Dartmouth College4002026-05-052026-07-15
Telemedicine Nutritional Counseling for Cancer Cachexia in Pakistan
Telemedicine-Delivered Nutritional Counseling, Standard In-Person Nutritional Counseling - Cachexia; Cancer; Sarcopenia
Not applicableActive not recruitingKing Edward Medical University802026-05-012026-06-08
Intestinal Microbiota Transplantation for Treating Advanced Tumor Cachexia
FMT capsule - Cachexia; Cancer, Fecal Microbiota Transplantation (FMT)
Phase 2Not yet recruitingHua Jiang662026-05-012026-04-16
A Clinical Study of Nanocrystalline Megestrol Acetate in Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer
Nanocrystalline Megestrol Acetate Oral Suspension - Locally Advanced Cervical Cancer, Cachexia
Phase 1RecruitingSecond Xiangya Hospital of Central South University882026-04-302026-04-24
Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia
DS010 injection - Cancer, Cachexia
Phase 1 / Phase 2Not yet recruitingDartsbio Pharmaceuticals Ltd.582026-04-302026-04-15
Spatial Multi-omics and Intelligent Early Warning of Pancreatic Cancer Cachexia
Pancreatic Cancer, Cachexia; Cancer; Sarcopenia
RecruitingPeking Union Medical College Hospital5002026-04-242026-06-26
Visugromab in Cachexia International Trial
Visugromab (CTL-002), Placebo - Cancer-associated Cachexia
Phase 2 / Phase 3RecruitingCatalYm GmbH5182026-04-162026-09-22
Study on the Pathogenesis and Reversal Strategies of Cancer Cachexia Based on Multi-Omics
Validation of intervention efficacy through enhanced intervention in nutritionally high-risk patients, Standard nutritional intervention was administered as a positive control to validate experimental efficacy., Administration of placebo as a negative control to validate experimental efficacy - Cachexia; Cancer; Sarcopenia
Not applicableRecruitingChina Medical University, China10002026-03-182026-04-09
Reduced Dosage and/or Visitation Protocol for the Treatment of Acute Malnutrition in Kenya
WHO-reduced, WHO-full, Kenya-IMAM - Acute Malnutrition in Childhood, Acute Malnutrition, Severe
Not applicableNot yet recruitingInternational Food Policy Research Institute22742026-03-012026-02-19
Effectiveness of Small-Quantity vs Medium-Quantity Lipid-Based Nutrient Supplements for Prevention of Undernutrition in Young Children
Medium-quantity lipid-based nutrient supplement (MQ-LNS), Small-quantity lipid-based nutrient supplement (SQ-LNS) - Undernutrition
Not applicableRecruitingAga Khan University15682026-02-262026-09-03

Showing 20 of 300. Sign in to see all of them.

Narrower conditions

Neoplasms (77)  ·  Anorexia (43)  ·  Malnutrition (43)  ·  Weight Loss (30)  ·  Pancreatic Neoplasms (29)  ·  Carcinoma, Non-Small-Cell Lung (27)  ·  Growth Disorders (25)  ·  Sarcopenia (24)  ·  Lung Neoplasms (16)  ·  Severe Acute Malnutrition (15)  ·  Motor Activity (14)  ·  Muscular Atrophy (14)  ·  Pulmonary Disease, Chronic Obstructive (13)  ·  Thinness (13)

Broader conditions

Pathological Conditions, Signs and Symptoms (300)  ·  Signs and Symptoms (300)  ·  Body Weight Changes (294)  ·  Body Weight (293)  ·  Thinness (287)  ·  Weight Loss (270)  ·  Neoplasms by Site (89)  ·  Nutritional and Metabolic Diseases (79)  ·  Nutrition Disorders (72)  ·  Neoplasms (71)  ·  Pathologic Processes (66)  ·  Digestive System Diseases (54)  ·  Respiratory Tract Diseases (54)  ·  Lung Diseases (52)  ·  Signs and Symptoms, Digestive (51)

Interventions

Megestrol Acetate (14)  ·  Exercise (7)  ·  Standard of Care (6)  ·  Blood Specimen Collection (4)  ·  Olanzapine (4)  ·  GSK2881078 (3)  ·  Ibuprofen (3)  ·  Infliximab (3)  ·  Nutrition Assessment (3)  ·  Amoxicillin (2)  ·  Cholecalciferol (2)  ·  Cyproheptadine (2)  ·  Diet Therapy (2)  ·  Dietary Supplements (2)  ·  Enteral Nutrition (2)

Sponsors

International Food Policy Research Institute (7)  ·  National Taiwan University Hospital (6)  ·  Pfizer (6)  ·  University of Erlangen-Nürnberg Medical School (6)  ·  Aga Khan University (5)  ·  GlaxoSmithKline (5)  ·  M.D. Anderson Cancer Center (5)  ·  Norwegian University of Science and Technology (5)  ·  The University of Texas Medical Branch, Galveston (5)  ·  Helsinn Therapeutics (U.S.), Inc (4)  ·  Novartis Pharmaceuticals (4)  ·  University of Edinburgh (4)  ·  Wake Forest University Health Sciences (4)  ·  Alliance for Clinical Trials in Oncology (3)  ·  Andrew Hendifar, MD (3)

Countries

United States (90)  ·  United Kingdom (23)  ·  Germany (21)  ·  China (20)  ·  Canada (17)  ·  France (14)  ·  Italy (12)  ·  Pakistan (12)  ·  Poland (12)  ·  Taiwan (12)  ·  Belgium (10)  ·  India (10)  ·  Denmark (8)  ·  Kenya (8)  ·  Netherlands (8)

Top investigators

Aminah Jatoi, MD (4)  ·  Andrew Hendifar, MD (2)  ·  Annemie Schols, PhD (2)  ·  Dejan Reljic, Dr. (2)  ·  Elodie Becquey, PhD (2)  ·  Ihab Tewfik, PhD (2)  ·  Lieven Huybregts, PhD (2)  ·  Lynn D Kramer, MD (2)  ·  Mark J Manary, MD (2)  ·  Melinda Sheffield-Moore, Ph.D. (2)  ·  Melinda Sheffield-Moore, PhD (2)

Results publications

PMID 28472437, PMID 26906526, PMID 39992021, PMID 42665333, PMID 11786587, PMID 12457271, PMID 12648025, PMID 14602249, PMID 15197210, PMID 15778874, PMID 15857739, PMID 16314085, PMID 16317825, PMID 16376734, PMID 16408219, PMID 1666930, PMID 16843954, PMID 16849753, PMID 17566383, PMID 17589370, PMID 17662149, PMID 17674351, PMID 18257397, PMID 18293016, PMID 18402303, PMID 18728826, PMID 18989154, PMID 19342610, PMID 19587829, PMID 19665818, PMID 19883531, PMID 19896326, PMID 20060626, PMID 20076976, PMID 20392703, PMID 20937647, PMID 21093718, PMID 21296615, PMID 21343383, PMID 21448087, PMID 21475692, PMID 22076835, PMID 22419719, PMID 22795905, PMID 22831162, PMID 23006802, PMID 23141881, PMID 23439759, PMID 23499390, PMID 24067666

NIH funding

2018 (2), R01CA127971 (2), U10CA081920 (2), 2017 (1), 2023 (1), 2025 (1), K01TW009987 (1), P30CA012197 (1), P30CA043703 (1), P30CA069533 (1), R01AR060209 (1), R01HD103642 (1), R33HD110150 (1), R43AR054993 (1), R44AR054993 (1)